| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |